Hepatitis B therapy: The plot thickens

被引：21

作者：

Malik, AH ^{[1
]}

Lee, WM ^{[1
]}

机构：

[1] Univ Texas, SW Med Sch, Dept Internal Med, Div Digest Dis & Hepatol, Dallas, TX 75235 USA

来源：

HEPATOLOGY | 1999年 / 30卷 / 02期

关键词：

D O I：

10.1002/hep.510300238

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：579 / 581

页数：3

共 31 条

[1] Identification and characterization of mutations in hepatitis B virus resistant to lamivudine [J].

Allen, MI ;

Deslauriers, M ;

Andrews, CW ;

Tipples, GA ;

Walters, KA ;

Tyrrell, DLJ ;

Brown, N ;

Condreay, LD .

HEPATOLOGY, 1998, 27 (06) :1670-1677

[2]

Atkins M, 1998, HEPATOLOGY, V28, p319A

[3] WHICH PATIENTS WITH CHRONIC HEPATITIS-B VIRUS-INFECTION WILL RESPOND TO ALPHA-INTERFERON THERAPY - A STATISTICAL-ANALYSIS OF PREDICTIVE FACTORS [J].

BROOK, MG ;

KARAYIANNIS, P ;

THOMAS, HC .

HEPATOLOGY, 1989, 10 (05) :761-763

[4] NATURAL COURSE AND RESPONSE TO INTERFERON OF CHRONIC HEPATITIS-B ACCOMPANIED BY ANTIBODY TO HEPATITIS-B-E ANTIGEN [J].

BRUNETTO, MR ;

OLIVERI, F ;

ROCCA, G ;

CRISCUOLO, D ;

CHIABERGE, E ;

CAPALBO, M ;

DAVID, E ;

VERME, G ;

BONINO, F .

HEPATOLOGY, 1989, 10 (02) :198-202

[5] HEPATITIS-B VIRUS UNABLE TO SECRETE E-ANTIGEN AND RESPONSE TO INTERFERON IN CHRONIC HEPATITIS-B [J].

BRUNETTO, MR ;

GIARIN, M ;

SARACCO, G ;

OLIVERI, F ;

CALVO, P ;

CAPRA, G ;

RANDONE, A ;

ABATE, ML ;

MANZINI, P ;

CAPALBO, M ;

PIANTINO, P ;

VERME, G ;

BONINO, F .

GASTROENTEROLOGY, 1993, 105 (03) :845-850

[6] Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy [J].

Chayama, K ;

Suzuki, Y ;

Kobayashi, M ;

Tsubota, A ;

Hashimoto, M ;

Miyano, Y ;

Koike, H ;

Kobayashi, M ;

Koida, I ;

Arase, Y ;

Saitoh, S ;

Murashima, N ;

Ikeda, K ;

Kumada, H .

HEPATOLOGY, 1998, 27 (06) :1711-1716

[7]

Colledge D, 1997, HEPATOLOGY, V26, P216

[8] Lamivudine treatment for one year in previously untreated US hepatitis B patients: Histologic improvement and hepatitis Be-antigen (HBeAg) seroconversion. [J].

Dienstag, J ;

Schiff, E ;

Wright, T ;

Perrillo, R ;

Hann, HW ;

Crowther, L ;

Woessner, M ;

Rubin, M ;

Brown, N .

GASTROENTEROLOGY, 1998, 114 (04) :A1235-A1235

[9] Therapy of chronic viral hepatitis [J].

Fried, MW .

MEDICAL CLINICS OF NORTH AMERICA, 1996, 80 (05) :957-&

[10] Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC (3TC) resistance [J].

Fu, L ;

Cheng, YC .

BIOCHEMICAL PHARMACOLOGY, 1998, 55 (10) :1567-1572

← 1 2 3 4 →